Remove Branding Remove Pharmacy Remove Regulation
article thumbnail

Pharma brands must ‘up the ante’ in their digital presence

pharmaphorum

Each country has different regulations in regard to the online advertising of prescription drugs and over-the-counter medicines. In the UK, Google allows the promotion of online pharmacies providing they follow Google’s procedures and are registered with the relevant pharmaceutical authorities in the countries their ad campaign targets.

Branding 124
article thumbnail

Supply chain middlemen ‘pocket half of US branded medicine spending’

pharmaphorum

In 2020, over half of total spending on brand medicines went to the supply chain, middlemen and other stakeholders, overtaking the amount going to drug manufacturers for the first time, according to a new study. ” The post Supply chain middlemen ‘pocket half of US branded medicine spending’ appeared first on. .

Branding 111
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The social media problem for healthcare

World of DTC Marketing

From my estimates, most of it failed because pharma companies are afraid of misinformation concerning regulations around DTC marketing. It was reported this week by The Guardian that ads from brands like Nike, Amazon, Honda, Walgreens, eBay, and other substantial advertisers were popping up all over anti-vax sites.

Branding 224
article thumbnail

Disruption in healthcare is coming

World of DTC Marketing

The company has hired former senior health regulators to help it navigate America’s healthcare bureaucracy. . Generic drugs versus branded is also a considerable expense. If pharmacies try to fill those generic prescriptions, the claims are rejected.

Pharmacy 227
article thumbnail

Do generics producers have what it takes to tackle complex and specialty drugs?

Pharmaceutical Technology

For example, JAK inhibitors are oral drugs that feature a certain complexity, says Jonathan Watanabe, PhD, professor of Clinical Pharmacy at the University of California, Irvine. Unlike biosimilars, it is simpler for small molecule specialty generics to establish equivalence to their branded forms, explains Vasquez.

Drugs 298
article thumbnail

PBM Industry Update: Trends, Challenges, and What's Ahead (NEW Live Video Webinar)

Drug Channels

for an exclusive deep dive into the latest trends, data, and strategies shaping the pharmacy benefit management (PBM) industry. Drawing from the brand-new 2025 Economic Report on U.S. WHAT YOU WILL LEARN Join industry expert Adam J. Fein, Ph.D., Emerging controversies, challenges, and threats to watch in the industry And much more!

article thumbnail

Breaking Down the Cost of Generic Drug Production: Understanding the Factors Influencing Affordability

Drug Patent Watch

Generic drug production involves replicating a brand-name medication's active ingredient, formulation, and dosage. Manufacturers must navigate a complex web of laws and regulations, including those related to patent protection, intellectual property, and safety standards. Let's start with the basics. Sounds straightforward, right?